Startup says algorithm identifies new risk factor for heart disease but a doctor is skeptical – MedCity News

An Israeli biotech company recently said that a study has endorsed what it describes as a new risk factor for heart disease as analyzed by the company’s proprietary algorithm.

The predictive power of the factor – variation in heart rate – was borne out by a clinical study led by Dr. Ilan Goldenberg, director of clinical cardiovascular research at the University of Rochester Medical Center.

Click here to read full article

Font Resize